Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Shares Issued (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Shares Issued data on record, last reported at $1.0 million in Q3 2025.

  • For Q3 2025, Shares Issued changed 0.0% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $2.0 million, down 33.33%, while the annual FY2025 figure was $2.0 million, 33.33% down from the prior year.
  • Shares Issued reached $1.0 million in Q3 2025 per INDV's latest filing, roughly flat from $1.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $2.0 million in Q1 2024 and bottomed at $1.0 million in Q3 2024.